Stay updated with the latest pharmacovigilance-programme-of-india news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on pharmacovigilance-programme-of-india topics.
New Delhi [India], April 4 (ANI): The Indian Pharmacopoeia Commission ( IPC), which acts as the National Coordination Centre for the Pharmacovigilance Programme of India (PvPI) and provides evidence-based research to CDSCO, will be monitoring the safety of weight loss drugs. The Indian Pharmacopoeia Commission will be compiling a report of adverse events which are associated with the GLP-1 drugs. Also Read | Indian Railways Carries 1,670 MT Freight, Runs 25,000 Trains Daily in Financial Year 20 ...Read More >
New Delhi [India], April 4 (ANI): The Indian Pharmacopoeia Commission ( IPC), which acts as the National Coordination Centre for the Pharmacovigilance Programme of India (PvPI) and provides evidence-based research to CDSCO, will be monitoring the safety of weight loss drugs. The Indian Pharmacopoeia Commission will be compiling a report of adverse events which are associated with the GLP-1 drugs. According to the Official sources, the IPC has started the regular monitoring of adverse events of ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.